- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Acutus Medical, Inc.: Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter | 155 | GlobeNewswire (Europe) | CARLSBAD, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and... ► Artikel lesen | |
| Mi | Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 3 | GlobeNewswire (USA) | ||
| 09.01. | Acutus Medical picks new CFO from within, announces 2023 guidance | 4 | MassDevice | ||
| 09.01. | Acutus Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.01. | Acutus Medical sees Q4 revenue $4.7M-$4.9M above estimates; appoints Takeo Mukai as CFO | 1 | Seeking Alpha | ||
| ACUTUS MEDICAL Aktie jetzt für 0€ handeln | |||||
| 09.01. | Acutus Medical Sees Q4, FY22 Revenues Well Above Estimates; Appoints Takeo Mukai As CFO | 1 | RTTNews | ||
| 09.01. | Acutus Medical, Inc.: Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer | 350 | GlobeNewswire (Europe) | CARLSBAD, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias... ► Artikel lesen | |
| 03.01. | Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| 29.12.22 | Acutus Medical, Inc.: Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium | 8 | GlobeNewswire (USA) | ||
| 21.12.22 | Medtronic to pay Acutus $17M following EU MDR submission of left-heart access portfolio | 24 | MassDevice | ||
| 21.12.22 | Acutus stock rises as Medtronic to pay $17M milestone under heart device pact | 19 | Seeking Alpha | ||
| 21.12.22 | Acutus Medical, Inc.: Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic | 344 | GlobeNewswire (Europe) | CARLSBAD, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias... ► Artikel lesen | |
| 19.12.22 | Acutus Medical fully launches next-gen heart ultrasound software | 4 | MassDevice | ||
| 19.12.22 | Acutus Medical, Inc.: Acutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5 | - | GlobeNewswire (USA) | ||
| 06.12.22 | Acutus Medical, Inc.: Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter | - | GlobeNewswire (USA) | ||
| 05.12.22 | Medtronic begins distributing Acutus AcQCross sheath-compatible septal crossing devices | 8 | MassDevice | ||
| 05.12.22 | Acutus Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.12.22 | Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| 10.11.22 | Acutus Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 09.11.22 | Acutus Medical, Inc.: Acutus Medical Reports Third Quarter 2022 Financial Results | 117 | GlobeNewswire (Europe) | CARLSBAD, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias... ► Artikel lesen |
Seite:
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 28,070 | -0,71 % | Teladoc Health, Inc.: Teladoc Health to Announce Fourth Quarter 2022 Financial Results | ||
| 1LIFE HEALTHCARE | 14,970 | 0,00 % | FTC reportedly hiring outside economists to probe Amazon's One Medical deal | ||
| INARI MEDICAL | 56,25 | 0,00 % | Inari Medical, Inc.: Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference | ||
| PROGYNY | 33,430 | -6,04 % | Progyny, Inc. Announces Third Quarter 2022 Results | Receives Record Number of New Client Commitments in Selling SeasonReports Record Quarterly Revenue of $205.4 Million, Reflecting 68% Growth Over the Prior Year PeriodRaises Full Year 2022 Guidance... ► Artikel lesen | |
| ADAPTHEALTH | 20,140 | -5,89 % | AdaptHealth Corp. Announces Third Quarter 2022 Results and Updates 2022 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| SIGNIFY HEALTH | 28,245 | 0,00 % | Opening Bell: CVS Health, Signify Health, Vertex, BP, NIO, Xpeng, Li Auto, Bed Bath & Beyond | Weitere Videos findet Ihr unter: https://www.deraktionaer.tv Die US-Börsen blieben gestern aufgrund eines Feiertages geschlossen. Vor dem Wochenende war der Dow Jones mit einem Minus von gut einem Prozent... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 25,820 | -0,54 % | Analyst Expectations for Privia Health Group's Future | ||
| AGILON HEALTH | 21,270 | 0,00 % | agilon health Reports Third Quarter 2022 Results | AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the third quarter... ► Artikel lesen | |
| ATRICURE | 44,090 | 0,00 % | AtriCure, Inc.: AtriCure Announces the First Patient Treated in the LeAAPS Clinical Trial | Trial will evaluate the safety and effectiveness of the AtriCure AtriClip Left Atrial Appendage Exclusion System for stroke prevention in cardiac surgery patients AtriCure, Inc. (Nasdaq: ATRC)... ► Artikel lesen | |
| TRANSMEDICS GROUP | 66,08 | 0,00 % | Pre-market Movers: Horizon Therapeutics, Retractable Technologies, Appreciate Holdings, TransMedics, CrowdStrike | SUNNYVALE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.40 A.M. ET).In the Green Horizon Therapeutics Public Limited Company (HZNP)... ► Artikel lesen | |
| FRESENIUS | 27,230 | +0,41 % | Research-Fazits zu Airbus, Fresenius, Aurubis ... | BERENBERG SENKT AIRBUS AUF 'SELL' (HOLD) - ZIEL 100 (120) EURBERENBERG SENKT ZIEL FÜR FMC AUF 46,83 (49,05) EUR - 'BUY'BERENBERG SENKT ZIEL FÜR FRESENIUS SE AUF 44,50 (45,95) EUR - 'BUY'BOFA HEBT ZIEL... ► Artikel lesen | |
| OUTSET MEDICAL | 29,040 | -0,62 % | Outset Medical Reports Third Quarter 2022 Financial Results | SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and... ► Artikel lesen | |
| SYNLAB | 8,405 | -18,40 % | ROUNDUP: Synlab rechnet 2023 mit weniger Umsatz und operativem Gewinn | MÜNCHEN (dpa-AFX) - Der Laborspezialist Synlab hat seine Jahresziele wegen einer geringeren Nachfrage und niedrigeren Preisen bei seinen Corona-Tests nach unten korrigiert. Der ohnehin in Aussicht... ► Artikel lesen | |
| GOODRX | 5,410 | -6,24 % | FTC prescribes GoodRx a $1.5m pill after 'sharing health info' with web giants | ||
| PROCEPT BIOROBOTICS | 36,830 | -5,81 % | PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance | REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing... ► Artikel lesen |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
